DiviDrip · JSPRW

JSPRW — Jasper Therapeutics, Inc.

Stock Warrant

WARRANT

Japer Therapeutics, Inc. Warrants

Underlying stock
Exercise price
Exchange
To Break-Even
Expires In2026-09-24

No redemption notice detected. Our weekly 8-K watcher runs every Friday and stamps this card if the issuer files a redemption 8-K.

$
Break-even (underlying)
Unrealized P/L
Intrinsic value
$0.00
max(0, underlying − strike)
Time value
$0.01
warrant price − intrinsic

JSPRW is Jasper Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.01. Capital Quality Rank: 45/100 — Stagnant mediocrity.

Stock snapshot

Price$0.01
Market cap
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)45 / 100 · Stagnant mediocrity
Shareholder buyback yield0.00%
Altman Z-score zoneDistress

About JSPRW

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Listed2021Employees22HQRedwood City, CASectorHealthcareWebsitejaspertherapeutics.com

Related non-dividend companies

Other non-dividend stocks investors research alongside JSPRW. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is JSPRW's current stock price?

JSPRW (Jasper Therapeutics, Inc.) is currently trading at $0.01.

Does JSPRW pay a dividend?

JSPRW (Jasper Therapeutics, Inc.) does not currently pay a regular dividend.

What is JSPRW's Capital Quality Rank?

JSPRW has a Capital Quality Rank of 45/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track JSPRW in DiviDrip

Add JSPRW to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow